Monoclonal antibody specific for human B-cells
US4831117A · kind A · utility
15Cited by
0References
2Claims
0Family size
Inventor
Key dates
| Filing date | Jan 3, 1986 |
| Grant date | May 16, 1989 |
| Priority date | — |
| Expiry date | Jan 3, 2006 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/808
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A hybrid cell line yields a monoclonal antibody which is highly restricted to B-lineage lymphoblastic leukemia cells and their progenitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.